These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 16594752)

  • 41. Successful treatment of a classic Hodgkin lymphoma-type post-transplant lymphoproliferative disorder with tailored chemotherapy and Epstein-Barr virus-specific cytotoxic T lymphocytes in a pediatric heart transplant recipient.
    Basso S; Zecca M; Calafiore L; Rubert L; Fiocchi R; Paulli M; Quartuccio G; Guido I; Sebastiani R; Croci GA; Beschi C; Nardiello I; Ginevri F; Cugno C; Comoli P
    Pediatr Transplant; 2013 Nov; 17(7):E168-73. PubMed ID: 23992468
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gene expression profiling of Epstein-Barr virus-positive and -negative monomorphic B-cell posttransplant lymphoproliferative disorders.
    Craig FE; Johnson LR; Harvey SA; Nalesnik MA; Luo JH; Bhattacharya SD; Swerdlow SH
    Diagn Mol Pathol; 2007 Sep; 16(3):158-68. PubMed ID: 17721324
    [TBL] [Abstract][Full Text] [Related]  

  • 43. BCL6 expression correlates with monomorphic histology in children with posttransplantation lymphoproliferative disease.
    Porter CC; Liang X; Gralla J; McGavran L; Albano EA
    J Pediatr Hematol Oncol; 2008 Sep; 30(9):684-8. PubMed ID: 18776761
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Post-transplant lymphoproliferative disorders. Molecular analysis of histogenesis and pathogenesis.
    Capello D; Berra E; Cerri M; Gaidano G
    Minerva Med; 2004 Feb; 95(1):53-64. PubMed ID: 15041926
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Array-CGH predicts prognosis in plasma cell post-transplantation lymphoproliferative disorders.
    Sarkozy C; Kaltenbach S; Faurie P; Canioni D; Berger F; Traverse-Glehen A; Ghesquieres H; Salles G; Bachy E; Alyanakian MA; Hermine O; Neven B; Macintyre E; Romana S; Molina TJ; Suarez F; Asnafi V; Bruneau J
    Genes Chromosomes Cancer; 2017 Mar; 56(3):221-230. PubMed ID: 27750397
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The spectrum of lymphoproliferations and malignant lymphoma after organ transplant].
    Müller-Hermelink HK; Ott G; Kneitz B; Rüdiger T
    Verh Dtsch Ges Pathol; 2004; 88():63-8. PubMed ID: 16892535
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transformation of BCR-deficient germinal-center B cells by EBV supports a major role of the virus in the pathogenesis of Hodgkin and posttransplantation lymphomas.
    Bechtel D; Kurth J; Unkel C; Küppers R
    Blood; 2005 Dec; 106(13):4345-50. PubMed ID: 16131568
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genomic variations in EBNA3C of EBV associate with posttransplant lymphoproliferative disorder.
    Maloney EM; Busque VA; Hui ST; Toh J; Fernandez-Vina M; Krams SM; Esquivel CO; Martinez OM
    JCI Insight; 2020 Mar; 5(6):. PubMed ID: 32213705
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Histogenetic phenotypes of B cells in posttransplant lymphoproliferative disorders by immunohistochemical analysis correlate with transplant type: solid organ vs hematopoietic stem cell transplantation.
    Novoa-Takara L; Perkins SL; Qi D; Shidham VB; Vesole DH; Hariharan S; Luo Y; Ewton A; Chang CC
    Am J Clin Pathol; 2005 Jan; 123(1):104-12. PubMed ID: 15762285
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Post-transplant lymphoproliferative disorders, Epstein-Barr virus infection, and disease in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.
    Allen UD; Preiksaitis JK;
    Clin Transplant; 2019 Sep; 33(9):e13652. PubMed ID: 31230381
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Risk factors and prognosis in T-cell posttransplantation lymphoproliferative diseases: reevaluation of 163 cases.
    Tiede C; Maecker-Kolhoff B; Klein C; Kreipe H; Hussein K
    Transplantation; 2013 Feb; 95(3):479-88. PubMed ID: 23296147
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hodgkin disease-like posttransplantation lymphoproliferative disorder of donor origin in a renal allograft recipient.
    Schlieper G; Kurschat C; Donner A; Huckenbeck W; Rüdiger T; Sandmann W; Grabensee B; Ivens K; Heering P
    Am J Kidney Dis; 2006 Mar; 47(3):e37-41. PubMed ID: 16490613
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Thoracic presentations of posttransplant lymphoproliferative disorders.
    Halkos ME; Miller JI; Mann KP; Miller DL; Gal AA
    Chest; 2004 Dec; 126(6):2013-20. PubMed ID: 15596707
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Posttransplant lymphoproliferative disorder in pediatric patients.
    Hussein K; Tiede C; Maecker-Kolhoff B; Kreipe H
    Pathobiology; 2013; 80(6):289-96. PubMed ID: 24013821
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical and pathological features of posttransplantation lymphoproliferative disorders presenting with skin involvement in 4 patients.
    Beynet DP; Wee SA; Horwitz SS; Kohler S; Horning S; Hoppe R; Kim YH
    Arch Dermatol; 2004 Sep; 140(9):1140-6. PubMed ID: 15381556
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Posttransplantation lymphoproliferative disorders in pediatric thoracic organ recipients.
    Boyle GJ; Michaels MG; Webber SA; Knisely AS; Kurland G; Cipriani LA; Griffith BP; Fricker FJ
    J Pediatr; 1997 Aug; 131(2):309-13. PubMed ID: 9290623
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Posttransplantation lymphoproliferative disorder in a renal allograft recipient.
    Goral S; Felgar R; Shappell S
    Am J Kidney Dis; 1997 Aug; 30(2):301-7. PubMed ID: 9261047
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Small intestinal involvement by lymphoproliferative disorders post-renal transplantation: a report from the post-transplant lymphoproliferative disorder international survey.
    Khedmat H; Taheri S
    Saudi J Kidney Dis Transpl; 2013 May; 24(3):487-94. PubMed ID: 23640619
    [TBL] [Abstract][Full Text] [Related]  

  • 59. EBV-specific T-cell immunity in pediatric solid organ graft recipients with posttransplantation lymphoproliferative disease.
    Wilsdorf N; Eiz-Vesper B; Henke-Gendo C; Diestelhorst J; Oschlies I; Hussein K; Pape L; Baumann U; Tönshoff B; Pohl M; Höcker B; Wingen AM; Klapper W; Kreipe H; Schulz TF; Klein C; Maecker-Kolhoff B
    Transplantation; 2013 Jan; 95(1):247-55. PubMed ID: 23222899
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hodgkin lymphoma post-transplant lymphoproliferative disorder following pediatric renal transplant: serial imaging with F-18 FDG PET/CT.
    Makis W; Lisbona R; Derbekyan V
    Clin Nucl Med; 2010 Sep; 35(9):704-5. PubMed ID: 20706047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.